Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Real-World Experience in Pharmacovigilance

被引：1
|
作者：
Burke, Mary [1 ]
Sallman, David A. [2 ]
Denson, Ariel [3 ]
Nelson, Rebecca Jean [3 ]
Chan, Onyee [4 ]
Walker, Alison R. [4 ]
Padron, Eric [4 ]
Xie, Zhuoer [4 ]
Komrokji, Rami S. [4 ]
Lancet, Jeffrey [4 ]
Kuykendall, Andrew T. [4 ]
Tobon, Katherine [3 ]
Jain, Akriti Gupta [1 ]
Wang, Chen [1 ]
Al Ali, Najla H. [1 ,4 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Pharm, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187206
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax
    Chen, Evan C.
    Liu, Yiwen
    Harris, Courtney E.
    Winer, Eric S.
    Wadleigh, Martha
    Lane, Andrew A.
    Vedula, Rahul S.
    Lindsley, R. Coleman
    Copson, Kevin M.
    Charles, Anne
    Marty, Francisco
    Neuberg, Donna
    DeAngelo, Daniel J.
    Stone, Richard M.
    Luskin, Marlise R.
    Issa, Nicolas C.
    Garcia, Jacqueline S.
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 1934 - 1941
  • [2] Antifungal Prophylaxis: Impact on Outcomes of Newly Diagnosed AML Patients Treated with a Hypomethylating Agent and Venetoclax
    Chen, Evan C.
    Liu, Yiwen
    Winer, Eric S.
    Luskin, Marlise R.
    Wadleigh, Martha
    Lane, Andrew A.
    Vedula, Rahul S.
    Lindsley, Coleman
    Copson, Kevin
    Charles, Anne
    Neuberg, Donna S.
    Issa, Nicolas C.
    DeAngelo, Daniel J.
    Stone, Richard M.
    Garcia, Jacqueline S.
    BLOOD, 2021, 138
  • [3] Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax plus Hypomethylating Agent
    Gangat, Naseema
    Elbeih, Azeem
    Ghosoun, Nour
    Mccullough, Kristen
    Aperna, Fnu
    Johnson, Isla M.
    Abdelmagid, Maymona
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Elliott, Michelle
    Mangaonkar, Abhishek
    Matin, Aasiya
    Saliba, Antoine N.
    Torghabeh, Mehrdad Hefazi
    Litzow, Mark R.
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Badar, Talha
    Murthy, Hemant
    Foran, James
    Palmer, Jeanne
    Sproat, Lisa
    Khera, Nandita
    Yi, Cecilia Arana
    Yates, Samuel
    Sneider, Abigail
    Dworkin, Emily
    Patel, Anand A.
    Bazinet, Alexandre
    Senapati, Jayastu
    Bataller, Alex
    Dinardo, Courtney
    Kadia, Tapan
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (02) : 260 - 271
  • [4] Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US
    Vachhani, Pankit
    Ma, Esprit
    Xu, Tao
    Montez, Melissa
    Worth, Sarah
    Cheng, Wei-Han
    Werner, Michael
    Abbas, Jonathan
    Donnellan, William
    BLOOD, 2022, 140
  • [5] Hypomethylating Agent and Venetoclax in Newly Diagnosed and Relapsed CBF/::MYH11(+) Acute Myeloid Leukemia
    Feng, Ziyu
    Hu, Xiaohui
    Li, Weiyang
    Xu, Ting
    Xu, Yang
    Xue, Shengli
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Chen, Suning
    Sun, Aining
    Wu, Depei
    Wang, Ying
    BLOOD, 2024, 144 : 4287 - 4288
  • [6] Real-World Experience of Adults With Acute Myeloid Leukemia on Hypomethylating Agents With or Without Venetoclax at a Comprehensive Cancer Center
    Freeman, Tracelyn
    Williams, Kiersten
    Puto, Marcin
    Waller, Allyson
    McLaughlin, Eric M.
    Blachly, James S.
    Roddy, Julianna
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (01) : 40 - 50
  • [7] Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies
    Ucciero, Andrealuna
    Pagnoni, Federico
    Scotti, Lorenza
    Pisterna, Alessia
    Barone-Adesi, Francesco
    Gaidano, Gianluca
    Patriarca, Andrea
    Lunghi, Monia
    CANCERS, 2023, 15 (18)
  • [8] Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
    Matthews, Andrew H.
    Perl, Alexander E.
    Luger, Selina M.
    Gill, Saar I.
    Lai, Catherine
    Porter, David L.
    Skuli, Sarah
    Bruno, Ximena Jordan
    Carroll, Martin P.
    Freyer, Craig W.
    Carulli, Alison
    Babushok, Daria V.
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Stadtmauer, Edward A.
    Loren, Alison W.
    Paralkar, Vikram R.
    Maillard, Ivan P.
    Pratz, Keith W.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1254 - 1264
  • [9] Real-World Experience with Generic Venetoclax Plus Hypomethylating Agent Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia Patients in Resource-Limited Setting: A Single-Center Study from India
    Kachhwaha, Arjun
    Benson, Reshma
    Satadeve, Paras
    Gupta, Adamya
    Shah, Bibhant
    Dalton, Prisla
    Ronanki, Kavya
    Kumar, Karthik
    Singh, Sashi
    Nayak, Jhasaketan
    Nagpal, Nikhil
    Singh, Shalini
    Singh, Neha
    Chandra, Harish
    Nath, Uttam Kumar
    BLOOD, 2024, 144 : 6047 - 6048
  • [10] Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission
    Nguyen, Phillip C.
    Donati, Vanessa
    Vassili, Catherine
    Grigg, Andrew P.
    Tiong, Ing S.
    LEUKEMIA RESEARCH, 2022, 116
12345